These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
341 related articles for article (PubMed ID: 8232363)
1. Orobuccal dyskinesia associated with trihexyphenidyl therapy in a patient with Parkinson's disease. Hauser RA; Olanow CW Mov Disord; 1993 Oct; 8(4):512-4. PubMed ID: 8232363 [TBL] [Abstract][Full Text] [Related]
2. Serpentine tongue: A rare manifestation following initiation of levodopa therapy in a patient with Parkinson's disease. Prashantha DK; Pal PK Parkinsonism Relat Disord; 2009 Nov; 15(9):718-9. PubMed ID: 19157953 [No Abstract] [Full Text] [Related]
3. How to achieve maximum benefit for the patient with Parkinson's disease. Greer M Geriatrics; 1976 Apr; 31(4):89-96. PubMed ID: 4356 [No Abstract] [Full Text] [Related]
4. The drug treatment of Parkinson's disease. Morris JG Aust Fam Physician; 1984 May; 13(5 Suppl):6-8, 11. PubMed ID: 6497767 [TBL] [Abstract][Full Text] [Related]
5. Therapy of neurologic disorders in the elderly. Mancall EL; Covington TR; Alonso RJ Hosp Pract (Off Ed); 1984 Oct; 19(10):106E, 106I, 106L passim. PubMed ID: 6434551 [No Abstract] [Full Text] [Related]
6. Mental impairment in Parkinson's disease. The role of anticholinergic drugs. Meco G; Casacchia M; Lazzari R; Franzese A; Castellana F; Carta A; Iannuccelli M; Agnoli A Acta Psychiatr Belg; 1984; 84(4):325-35. PubMed ID: 6507124 [TBL] [Abstract][Full Text] [Related]
7. [Dyskinesia induced by anticholinergic drugs--electrophysiological analysis]. Mano T Rinsho Shinkeigaku; 1974 Mar; 14(3):255-65. PubMed ID: 4153837 [No Abstract] [Full Text] [Related]
15. [Anticholinergics and levodopa in Parkinson's disease: an unnecessary combination in patients treated for the 1st time]. Giménez-Roldán S; Mateo D; Gil Núñez A Rev Clin Esp; 1980 Dec; 159(6):403-7. PubMed ID: 7221107 [No Abstract] [Full Text] [Related]
16. Preventing and controlling dyskinesia in Parkinson's disease--a view of current knowledge and future opportunities. Jenner P Mov Disord; 2008; 23 Suppl 3():S585-98. PubMed ID: 18781676 [TBL] [Abstract][Full Text] [Related]
17. [A clinical analysis of L-dopa induced dyskinesia treated by posteroventral pallidotomy for Parkinson's disease]. Zhao G; Li Y; Shao M; Ding Y Zhonghua Wai Ke Za Zhi; 1999 Aug; 37(8):482-4. PubMed ID: 11829894 [TBL] [Abstract][Full Text] [Related]
18. [Therapeutic effects of L-dopa and trihexyphenidyl in Parkinson's disease--an examination by a double blind method]. Hirayama K; Uono M; Nakanishi T; Kato N; Nagao Y Shinkei Kenkyu No Shimpo; 1971; 15(1):267-85. PubMed ID: 4937721 [No Abstract] [Full Text] [Related]
19. Problems with long-term levodopa therapy for Parkinson's disease. Marsden CD Clin Neuropharmacol; 1994; 17 Suppl 2():S32-44. PubMed ID: 9358193 [TBL] [Abstract][Full Text] [Related]
20. Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis. Talati R; Baker WL; Patel AA; Reinhart K; Coleman CI Int J Clin Pract; 2009 Apr; 63(4):613-23. PubMed ID: 19222614 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]